 The government of Pakistan has taken several measures to improve access to cancer treatments, including reducing the time required to import unregistered drugs, decentralizing the authority of the Drug Regulatory Authority of Pakistan, DRAP, to reduce the burden, facilitating cancer centers and procuring imported medications, allowing hospitals facing inventory challenges to borrow an imported medicine item from a nearby hospital where it is available, exempting customs duties and taxes on. Imports of these medications, encouraging local manufacturing of generic drugs, abolishing regularity duties on imports of raw materials of said medications for the manufacturer of generic drugs, allowing multiple sources of drug import, and deriving an online process slash portal to communicate and update patients and hospitals for delays and implementing procedures to deal with such issues. This article was authored by S. An-Elihi and Adil Siddiqi.